Residency · New Brunswick, NJ
Sponsored by Saint Peter's University Hospital
Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome.
Transplantation and cellular therapy · 2023 · 331 citations · Kris Mahadeo
Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas.
The New England journal of medicine · 2021 · 288 citations · Sameer Sait
Haploidentical Bone Marrow Transplantation for Sickle Cell Disease.
NEJM evidence · 2025 · 39 citations · Kris Mahadeo
Tabelecleucel for allogeneic haematopoietic stem-cell or solid organ transplant recipients with Epstein-Barr virus-positive post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE): a phase 3, multicentre, open-label trial.
The Lancet. Oncology · 2024 · 75 citations · Kris Mahadeo
Autologous CD33-CAR-T cells for treatment of relapsed/refractory acute myelogenous leukemia.
Leukemia · 2021 · 177 citations · Kris Mahadeo
Influenza-Associated Acute Necrotizing Encephalopathy in US Children.
JAMA · 2025 · 28 citations · Kristina Feja
Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors.
Nature cancer · 2021 · 146 citations · Sameer Sait
Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA) and an update of novel therapies.
Leukemia · 2023 · 53 citations · Kris Mahadeo